Increased density of DISC1-immunoreactive oligodendroglial cells in fronto-parietal white matter of patients with paranoid schizophrenia.

作者: Hans-Gert Bernstein , Esther Jauch , Henrik Dobrowolny , Christian Mawrin , Johann Steiner

DOI: 10.1007/S00406-015-0640-Y

关键词:

摘要: Profound white matter abnormalities have repeatedly been described in schizophrenia, which involve the altered expression of numerous oligodendrocyte-associated genes. Transcripts disrupted-in-schizophrenia 1 (DISC1) gene, a key susceptibility factor recently shown to be expressed by oligodendroglial cells and negatively regulate oligodendrocyte differentiation maturation. To learn more about putative role(s) oligodendroglia-associated DISC1 we analyzed density DISC1-immunoreactive oligodendrocytes fronto-parietal postmortem brains patients with schizophrenia. Compared controls (N = 12) cases undifferentiated/residual schizophrenia (N = 6), there was significantly increased DISC1-expressing glial paranoid (N = 12), unlikely resulted from neuroleptic treatment. Pathophysiologically, over-expression protein(s) might add reduced levels two myelin markers, 2',3'-cyclic-nucleotide 3'-phosphodiesterase basic protein Moreover, it contribute cell cycle as well deficits maturation found

参考文章(69)
E Sprooten, J E Sussmann, T W Moorhead, H C Whalley, C ffrench-Constant, H P Blumberg, M E Bastin, J Hall, S M Lawrie, A M McIntosh, Association of white matter integrity with genetic variation in an exonic DISC1 SNP Molecular Psychiatry. ,vol. 16, pp. 688- 689 ,(2011) , 10.1038/MP.2011.15
Nagahide Takahashi, Takeshi Sakurai, Roles of glial cells in schizophrenia: possible targets for therapeutic approaches. Neurobiology of Disease. ,vol. 53, pp. 49- 60 ,(2013) , 10.1016/J.NBD.2012.11.001
Shingo Miyata, Tsuyoshi Hattori, Shoko Shimizu, Akira Ito, Masaya Tohyama, Disturbance of oligodendrocyte function plays a key role in the pathogenesis of schizophrenia and major depressive disorder. BioMed Research International. ,vol. 2015, pp. 492367- 492367 ,(2015) , 10.1155/2015/492367
Andrea Schmitt, Alkomiet Hasan, Oliver Gruber, Peter Falkai, Schizophrenia as a disorder of disconnectivity European Archives of Psychiatry and Clinical Neuroscience. ,vol. 261, pp. 150- 154 ,(2011) , 10.1007/S00406-011-0242-2
Woraphat Ratta-apha, Akitoyo Hishimoto, Kentaro Mouri, Kyoichi Shiroiwa, Toru Sasada, Masakuni Yoshida, Irwan Supriyanto, Yasuhiro Ueno, Migiwa Asano, Osamu Shirakawa, Hideru Togashi, Yoshimi Takai, Ichiro Sora, Association analysis of the DISC1 gene with schizophrenia in the Japanese population and DISC1 immunoreactivity in the postmortem brain Neuroscience Research. ,vol. 77, pp. 222- 227 ,(2013) , 10.1016/J.NEURES.2013.08.010
Victor Vostrikov, Natalya Uranova, Age-Related Increase in the Number of Oligodendrocytes Is Dysregulated in Schizophrenia and Mood Disorders Schizophrenia Research and Treatment. ,vol. 2011, pp. 174689- 174689 ,(2011) , 10.1155/2011/174689
Padraig Wright, Vishwajit L. Nimgaonkar, Peter T. Donaldson, Robin M. Murray, Schizophrenia and HLA: a review. Schizophrenia Research. ,vol. 47, pp. 1- 12 ,(2001) , 10.1016/S0920-9964(00)00022-0
Andrea Schmitt, Corinna Steyskal, Hans-Gert Bernstein, Thomas Schneider-Axmann, Eleni Parlapani, Evelin L. Schaeffer, Wagner F. Gattaz, Bernhard Bogerts, Christoph Schmitz, Peter Falkai, Stereologic investigation of the posterior part of the hippocampus in schizophrenia Acta Neuropathologica. ,vol. 117, pp. 395- 407 ,(2009) , 10.1007/S00401-008-0430-Y
Pavel Katsel, Kenneth L Davis, Celeste Li, Weilun Tan, Elizabeth Greenstein, Lisa B Kleiner Hoffman, Vahram Haroutunian, Abnormal Indices of Cell Cycle Activity in Schizophrenia and their Potential Association with Oligodendrocytes Neuropsychopharmacology. ,vol. 33, pp. 2993- 3009 ,(2008) , 10.1038/NPP.2008.19
Malin Hoistad, Devorah Segal, Nagahide Takahashi, Takeshi Sakurai, Joseph D Buxbaum, Patrick R Hof, Linking white and grey matter in schizophrenia: oligodendrocyte and neuron pathology in the prefrontal cortex Frontiers in Neuroanatomy. ,vol. 3, pp. 9- 9 ,(2009) , 10.3389/NEURO.05.009.2009